Trials / Completed
CompletedNCT01351467
Web-based Genetic Research on Parkinson's Disease
Ongoing, Web-Based Genome-Wide Association Studies for Targeted Disease Initiatives
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 13,576 (actual)
- Sponsor
- 23andMe, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine how genes and environment affect risk for Parkinson's disease.
Detailed description
23andMe has created a web-based Parkinson's research initiative to understand the genetic associations found between Parkinson's patients' DNA and their disease. To learn more, visit: https://www.23andme.com/pd/. You can participate in this research initiative without leaving home. If you are eligible to participate, we will send you an in-home 23andMe DNA kit at no cost. We will ask you short online surveys (15-20) about your Parkinson's journey, symptoms, and response to treatment. Enrollment is on-going and open to individuals who have been diagnosed with Parkinson's disease and are residents of the U.S. Participants receive access to ancestry information and uninterpreted genetic data. Participants will also receive regular updates on our research efforts and findings.
Conditions
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2021-06-23
- Completion
- 2021-06-23
- First posted
- 2011-05-11
- Last updated
- 2022-11-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01351467. Inclusion in this directory is not an endorsement.